Inhaled corticosteroids in COPD: friend or foe?
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
KM Kew, A Seniukovich - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary …
GT Ferguson, KF Rabe, FJ Martinez… - The Lancet …, 2018 - thelancet.com
Background Inhaled corticosteroids have been used in patients with chronic obstructive
pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not …
pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not …
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort …
Background Early descriptions of patients admitted to hospital during the COVID-19
pandemic showed a lower prevalence of asthma and chronic obstructive pulmonary disease …
pandemic showed a lower prevalence of asthma and chronic obstructive pulmonary disease …
Guidelines for the management of adult lower respiratory tract infections‐Full version
M Woodhead, F Blasi, S Ewig, J Garau… - Clinical microbiology …, 2011 - Wiley Online Library
Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …
Guidelines published in 2005 and now includes scientific publications through to May 2010 …
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Background The long-term natural history of chronic obstructive pulmonary disease (COPD)
in terms of successive severe exacerbations and mortality is unknown. Methods The authors …
in terms of successive severe exacerbations and mortality is unknown. Methods The authors …
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial
M Bafadhel, S McKenna, S Terry, V Mistry… - American journal of …, 2012 - atsjournals.org
Rationale: Exacerbations of chronic obstructive pulmonary disease (COPD) and responses
to treatment are heterogeneous. Objectives: Investigate the usefulness of blood eosinophils …
to treatment are heterogeneous. Objectives: Investigate the usefulness of blood eosinophils …
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …
however, a significant proportion of patients at low risk of exacerbations are treated with …
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
C Andréjak, R Nielsen, VØ Thomsen, P Duhaut… - Thorax, 2013 - thorax.bmj.com
Background Chronic respiratory disease and inhaled corticosteroid (ICS) therapy for chronic
obstructive pulmonary disease (COPD) increase the risk of pneumonia. Few data are …
obstructive pulmonary disease (COPD) increase the risk of pneumonia. Few data are …